Microbioloxía

2021

1. 6-Halopyridylmethylidene Penicillin-Based Sulfones Efficiently Inactivate the Natural Resistance of Pseudomonas aeruginosa to β-Lactam Antibiotics

   Journal of Medicinal Chemistry, Vol. 64, Núm. 9, pp. 6310-6328

2. A Large Multicenter Prospective Study of Community-Onset Healthcare Associated Bacteremic Urinary Tract Infections in the Era of Multidrug Resistance: Even Worse than Hospital Acquired Infections?

   Infectious Diseases and Therapy, Vol. 10, Núm. 4, pp. 2677-2699

3. A machine learning model for evaluating imported disease screening strategies in immigrant populations

   American Journal of Tropical Medicine and Hygiene, Vol. 105, Núm. 5, pp. 1413-1419

4. Activity of imipenem, meropenem, cefepime, and sulbactam in combination with the β-lactamase inhibitor ln-1-255 against acinetobacter spp.

   Antibiotics, Vol. 10, Núm. 2, pp. 1-15

5. Activity of imipenem/relebactam against a Spanish nationwide collection of carbapenemase-producing Enterobacterales

   Journal of Antimicrobial Chemotherapy, Vol. 76, Núm. 6, pp. 1498-1510

6. Advanced applications of MALDI-TOF: Identification and antibiotic susceptibility testing

   Application and Integration of Omics-powered Diagnostics in Clinical and Public Health Microbiology (Springer International Publishing), pp. 175-189

7. An Improved Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Data Analysis Pipeline for the Identification of Carbapenemase-Producing Klebsiella pneumoniae

   Journal of clinical microbiology, Vol. 59, Núm. 7, pp. e0080021

8. Application and perspectives of maldi–tof mass spectrometry in clinical microbiology laboratories

   Microorganisms, Vol. 9, Núm. 7

9. Azole and amphotericin B MIC values against aspergillus fumigatus: High agreement between spectrophotometric and visual readings using the EUCAST EDef 9.3.2 procedure

   Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 1

10. Azole resistance survey on clinical Aspergillus fumigatus isolates in Spain

    Clinical Microbiology and Infection, Vol. 27, Núm. 8, pp. 1170.e1-1170.e7

11. Bioinformatics approaches to the study of antimicrobial resistance

    Revista Espanola de Quimioterapia, Vol. 34, pp. 15-17

12. Blue light directly modulates the quorum network in the human pathogen Acinetobacter baumannii

    Scientific Reports, Vol. 11, Núm. 1

13. Clinical Features and Outcomes of Streptococcus anginosus Group Infective Endocarditis: A Multicenter Matched Cohort Study

    Open Forum Infectious Diseases, Vol. 8, Núm. 6

14. Clinical characteristics, aetiology and mortality/recurrence risk factors of acute cholangitis in patients with and without biliary stent

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 39, Núm. 9, pp. 445-450

15. Clinical management of cUTI, cIAI, and HABP/VABP attributable to carbapenem-resistant Gram-negative infections in Spain

    Revista Espanola de Quimioterapia, Vol. 34, Núm. 6, pp. 639-650

16. Clinitest rapid COVID-19 antigen test for the diagnosis of SARS-CoV-2 infection: A multicenter evaluation study

    Journal of Clinical Virology, Vol. 143

17. Clones of enterotoxigenic and Shiga toxin-producing Escherichia coli implicated in swine enteric colibacillosis in Spain and rates of antibiotic resistance

    Veterinary Microbiology, Vol. 252

18. Considerations on HTLV-1 infection in Spain

    Medicina Clinica

19. Crispr-cas, a revolution in the treatment and study of eskape infections: Pre-clinical studies

    Antibiotics, Vol. 10, Núm. 7

20. Distinct epidemiology and resistance mechanisms affecting ceftolozane/tazobactam in Pseudomonas aeruginosa isolates recovered from ICU patients in Spain and Portugal depicted by WGS

    The Journal of antimicrobial chemotherapy, Vol. 76, Núm. 2, pp. 370-379